BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Cerus Corporation Announces Record Fourth Quarter and Full Year 2018 Results

  Cerus Corporation (Nasdaq: CERS) today announced complete financial results for the fourth quarter and year ended December 31, 2018.

  February 26, 2019

   · 

  13 min read
• Business

  ACADIA Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

  ACADIA Pharmaceuticals Inc. announced its financial results for the fourth quarter and full year ended December 31, 2018.

  February 26, 2019

   · 

  12 min read
• Deals

  TCR2 Therapeutics Announces Exercise of Over-Allotment Option

  TCR2 Therapeutics Inc. announced that the underwriters of its recent initial public offering of common stock have exercised in full their over-allotment option and purchased an additional 750,000 shares at $15.00 per share, before deducting underwriting discounts and commissions.

  February 26, 2019

   · 

  2 min read
• Deals

  Veeva Announces Fourth Quarter and Fiscal Year 2019 Results

  Veeva Systems Inc. announced results for its fiscal fourth quarter and full year ended January 31, 2019. All results, including prior periods, and guidance reflect the new revenue recognition standard ASC 606.

  February 26, 2019

   · 

  26 min read
• Business

  Valens Signs Multi-Year Cannabis and Hemp Extraction Agreement with Tilray

  Valens GroWorks Corp. is pleased to announce that it has entered into a multi-year extraction services agreement, renewable annually after the initial two year term, to provide cannabis and hemp extraction services to Tilray Canada Ltd.

  February 26, 2019

   · 

  3 min read
• Deals

  Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets

  Synergy Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, confirmed that the previously announced agreement with Bausch Health Companies Inc.

  February 26, 2019

   · 

  6 min read
• Deals

  Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.

  Bausch Health and Synergy to Seek Bankruptcy Court Approval of Sale on March 1, 2019

  February 26, 2019

   · 

  5 min read
• Job Trends

  Region’s First Proton Therapy Cancer Treatment Coming to The University of Kansas Health System

  The University of Kansas Health System is announcing plans to bring lifesaving proton therapy treatment to cancer patients in Kansas and the surrounding region.

  February 26, 2019

   · 

  3 min read
• Deals

  Kewaunee Scientific Declares Quarterly Dividend and Reports Results for Third Quarter - February 26, 2019

  Kewaunee Scientific Corporation reported results for its third quarter of fiscal year 2019, ended January 31, 2019.

  February 26, 2019

   · 

  6 min read
• Deals

  CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today

  CStone Pharmaceuticals announced the listing of 186,396,000 shares on the Main Board of the Hong Kong Stock Exchange.

  February 26, 2019

   · 

  3 min read